Answer
Talvey (talquetamab) has no relevant use in the paediatric population for treating multiple myeloma.
Sources for this answer
- TALVEY 2 mg/mL solution for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 9Document updated
Sources checked